Regulations.gov document
Premarket Approval Response from FDA CDRH to Bard Peripheral Vascular, Inc. Fluency Plus…
Other · FDA-2014-M-0875 · posted Jul 16, 2014
Key facts
| Document ID | FDA-2014-M-0875-0001 |
|---|---|
| Title | Premarket Approval Response from FDA CDRH to Bard Peripheral Vascular, Inc. Fluency Plus Endovascular Stent Graft, P130029 |
| Document type | Other |
| Subtype | Approval |
| Agency | FDA |
| Docket | FDA-2014-M-0875 |
| Posted | Jul 16, 2014 |
| Comment period opens | Jul 16, 2014 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: